Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 243,302,496
  • Shares Outstanding, K 5,559,929
  • Annual Sales, $ 53,647 M
  • Annual Income, $ 11,152 M
  • 60-Month Beta 0.65
  • Price/Sales 4.54
  • Price/Cash Flow 10.39
  • Price/Book 4.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.78
  • Number of Estimates 4
  • High Estimate 0.81
  • Low Estimate 0.76
  • Prior Year 0.81
  • Growth Rate Est. (year over year) -3.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.28 +4.14%
on 05/29/19
44.29 -2.94%
on 06/25/19
+1.04 (+2.48%)
since 05/24/19
3-Month
38.42 +11.89%
on 04/18/19
44.29 -2.94%
on 06/25/19
+0.57 (+1.34%)
since 03/26/19
52-Week
36.00 +19.42%
on 07/02/18
46.47 -7.49%
on 12/04/18
+6.61 (+18.17%)
since 06/26/18

Most Recent Stories

More News
After Yesterday's Decline of 1.28%, Pfizer Inc Offers Investors Better Value

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $42.94 to a high of $44.17. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $43.31 on...

PFE : 42.99 (-1.76%)
Pfizer Inc Falls 1.28% on Heavy Volume: Watch For Potential Rebound

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $42.94 to a high of $44.17. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $43.31 on...

PFE : 42.99 (-1.76%)
Pfizer Opens Call for Proposals for Start-ups to Apply for LabCentral Residency

Pfizer Inc. opens a call for interested U.S. startup companies to submit non-confidential proposals for a Pfizer-sponsored LabCentral "Golden Ticket." A Golden Ticket will provide one year of bench space...

PFE : 42.99 (-1.76%)
Conatus' Emricasan Lags Primary Goal in Liver Function Study

Conatus' (CNAT) emricasan fails to meet the primary endpoint in the phase IIb ENCORE-LF study on decompensated NASH cirrhosis patients while the ENCORE-PH probe falls shy of the predefined objectives.

CNAT : 0.28 (-2.45%)
NVS : 91.20 (-1.27%)
ACOR : 6.93 (-1.84%)
PFE : 42.99 (-1.76%)
Pfizer (PFE) Flat As Market Sinks: What You Should Know

In the latest trading session, Pfizer (PFE) closed at $43.76, marking no change from the previous day.

PFE : 42.99 (-1.76%)
Abbvie Decides to Acquire Allergan

Abbvie Decides to Acquire Allergan

ABT : 82.96 (-1.52%)
ARRY : 46.12 (-0.19%)
AGN : 164.00 (+0.97%)
CZR : 11.62 (+0.52%)
ABBV : 68.00 (+3.50%)
ERI : 43.90 (+0.21%)
PFE : 42.99 (-1.76%)
AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20

AbbVie (ABBV) has agreed to purchase Botox maker Allergan (AGN) for roughly $63 billion in cash and stock.

ABT : 82.96 (-1.52%)
ARRY : 46.12 (-0.19%)
AGN : 164.00 (+0.97%)
CZR : 11.62 (+0.52%)
ABBV : 68.00 (+3.50%)
ERI : 43.90 (+0.21%)
PFE : 42.99 (-1.76%)
Pfizer Inc (PFE) Approaches New Upside Target of $44.03

Shares of Pfizer Inc (NYSE:PFE) have bullishly opened above the pivot of $43.72 today and have reached the first resistance level of $43.89. Should the shares continue to rise, the resistance pivots of...

PFE : 42.99 (-1.76%)
Thinking about trading options or stock in Alibaba, Coupa Software, Electronic Arts, Mallinckrodt, or Pfizer?

InvestorsObserver issues critical PriceWatch Alerts for BABA, COUP, EA, MNK, and PFE.

BABA : 168.99 (+1.92%)
COUP : 118.94 (-1.20%)
MNK : 8.50 (+1.19%)
EA : 97.32 (+0.43%)
PFE : 42.99 (-1.76%)
Why These Innovative Biotech ETFs Soaring

Strong M&A activity has sent shares of many small, innovative biotech companies surging

NVTA : 20.18 (-2.32%)
CELG : 92.41 (-0.84%)
SBIO : 34.64 (-1.31%)
ARKG : 32.14 (-0.56%)
ILMN : 356.37 (-0.48%)
ARRY : 46.12 (-0.19%)
MRK : 83.54 (-1.99%)
LLY : 111.34 (-3.48%)
PFE : 42.99 (-1.76%)
BMY : 44.92 (-1.86%)
BTEC : 32.83 (-0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade PFE with:

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

2nd Resistance Point 44.40
1st Resistance Point 43.69
Last Price 42.99
1st Support Level 42.39
2nd Support Level 41.80

See More

52-Week High 46.47
Last Price 42.99
Fibonacci 61.8% 42.47
Fibonacci 50% 41.24
Fibonacci 38.2% 40.00
52-Week Low 36.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar